Incidence, mechanisms, treatment, and outcomes of donor vessel injury during percutaneous coronary interventions for chronic total occlusion.

chronic total occlusion complications donor vessel injury percutaneous coronary intervention

Journal

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139

Informations de publication

Date de publication:
Oct 2023
Historique:
revised: 22 06 2023
received: 25 03 2023
accepted: 28 07 2023
pubmed: 10 8 2023
medline: 10 8 2023
entrez: 10 8 2023
Statut: ppublish

Résumé

Donor vessel injury is a potentially life-threatening complication of chronic total occlusion (CTO) percutaneous coronary intervention (PCI). Our goal was to examine the incidence, mechanisms, treatment, and outcomes of patients with donor vessel injury in a large multicenter CTO PCI registry. We analyzed the baseline clinical and angiographic characteristics, and procedural outcomes of 12,349 CTO PCIs performed between 2012 and 2022 at 44 centers. The incidence of donor vessel injury was 0.35% (n = 43). The baseline clinical characteristics of patients with and without donor vessel injury were similar. Cases complicated by donor vessel injury were more complex with higher Japanese CTO score (2.9 ± 1.1 vs. 2.4 ± 1.3; p = 0.004) and lower procedural success rate (69.8% vs. 85.2%; p = 0.004). The retrograde approach was used more commonly in donor vessel injury cases (68.9% vs. 30.9%; p < 0.001). Most (53.5%) donor vessel injuries were guide catheter-induced, whereas 20.9% were due to donor vessel thrombosis. Of the 43 patients with donor vessel injury, 36 (83.7%) were treated with stenting and seven (16.3%) received a left ventricular assist device. The incidence of major adverse cardiovascular events (MACEs) was significantly higher in cases with donor vessel injury (23.3% vs. 2.0%; p < 0.001). Of the 43 patients with donor vessel injury, five patients (11.6%) experienced acute myocardial infarction and four patients (9.3%) died. Donor vessel injury, occurred in 0.35% of CTO PCIs performed by experienced operators, was mainly due to guide catheter-induced dissection or thrombosis and was associated with lower procedural success and higher MACE.

Sections du résumé

BACKGROUND BACKGROUND
Donor vessel injury is a potentially life-threatening complication of chronic total occlusion (CTO) percutaneous coronary intervention (PCI).
AIMS OBJECTIVE
Our goal was to examine the incidence, mechanisms, treatment, and outcomes of patients with donor vessel injury in a large multicenter CTO PCI registry.
METHODS METHODS
We analyzed the baseline clinical and angiographic characteristics, and procedural outcomes of 12,349 CTO PCIs performed between 2012 and 2022 at 44 centers.
RESULTS RESULTS
The incidence of donor vessel injury was 0.35% (n = 43). The baseline clinical characteristics of patients with and without donor vessel injury were similar. Cases complicated by donor vessel injury were more complex with higher Japanese CTO score (2.9 ± 1.1 vs. 2.4 ± 1.3; p = 0.004) and lower procedural success rate (69.8% vs. 85.2%; p = 0.004). The retrograde approach was used more commonly in donor vessel injury cases (68.9% vs. 30.9%; p < 0.001). Most (53.5%) donor vessel injuries were guide catheter-induced, whereas 20.9% were due to donor vessel thrombosis. Of the 43 patients with donor vessel injury, 36 (83.7%) were treated with stenting and seven (16.3%) received a left ventricular assist device. The incidence of major adverse cardiovascular events (MACEs) was significantly higher in cases with donor vessel injury (23.3% vs. 2.0%; p < 0.001). Of the 43 patients with donor vessel injury, five patients (11.6%) experienced acute myocardial infarction and four patients (9.3%) died.
CONCLUSIONS CONCLUSIONS
Donor vessel injury, occurred in 0.35% of CTO PCIs performed by experienced operators, was mainly due to guide catheter-induced dissection or thrombosis and was associated with lower procedural success and higher MACE.

Identifiants

pubmed: 37560823
doi: 10.1002/ccd.30798
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

585-593

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Brilakis ES, Karmpaliotis D, Patel V, Banerjee S. Complications of chronic total occlusion angioplasty. Interv Cardiol Clin. 2012;1(3):373-389.
Karacsonyi J, Vemmou E, Nikolakopoulos ID, Ungi I, Rangan BV, Brilakis ES. Complications of chronic total occlusion percutaneous coronary intervention. Neth Heart J. 2021;29(1):60-67.
Moroni F, Santiago R, DI PIETRO R, Calcagno S, Azzalini L. Complications during chronic total occlusion percutaneous coronary intervention: a sign- and symptom-based approach to early diagnosis and treatment. Minerva Cardiol Angiol. 2021;69(6):773-786.
Brilakis ES. Manual of percutaneous coronary interventions: a step-by-step approach. Academic Press; 2021.
Rigger J, Hanratty CG, Walsh SJ. Common and uncommon CTO complications. Interv Cardiol Rev. 2018;13(3):121-125.
Brilakis ES. Manual of chronic total occlusion interventions: a step-by-step approach. 3rd edition. Academic Press; 2023.
El Sabbagh A, Patel VG, Jeroudi OM, et al. Angiographic success and procedural complications in patients undergoing retrograde percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 3,482 patients from 26 studies. Int J Cardiol. 2014;174(2):243-248.
Kostantinis S, Alaswad K, Karmpaliotis D, et al. Primary vs secondary retrograde approach in chronic total occlusion percutaneous coronary interventions. J Invasive Cardiol. 2022;34(9):672.
Sianos G, Barlis P, Di Mario C, et al. European experience with the retrograde approach for the recanalisation of coronary artery chronic total occlusions. A report on behalf of the euroCTO club. EuroIntervention. 2008;4(1):84-92.
Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inf. 2019;95:103208.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377-381.
Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation. 2012;126(16):2020-2035.
Morino Y, Abe M, Morimoto T, et al. Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 Minutes. JACC Cardiovasc Interv. 2011;4(2):213-221.
Christopoulos G, Kandzari DE, Yeh RW, et al. Development and validation of a novel scoring system for predicting technical success of chronic total occlusion percutaneous coronary interventions. JACC Cardiovasc Interv. 2016;9(1):1-9.
Simsek B, Kostantinis S, Karacsonyi J, et al. Predicting periprocedural complications in chronic total occlusion percutaneous coronary intervention. JACC Cardiovasc Interv. 2022;15(14):1413-1422.
Kostantinis S, Simsek B, Karacsonyi J, et al. Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation score. EuroIntervention. 2023;18(12):1022-1030.
Brilakis ES, Mashayekhi K, Tsuchikane E, et al. Guiding principles for chronic total occlusion percutaneous coronary intervention. Circulation. 2019;140(5):420-433.
Kostantinis S, Simsek B, Karacsonyi J, et al. In-hospital outcomes and temporal trends of percutaneous coronary interventions for chronic total occlusion. EuroIntervention. 2022;18:e929-e932.
Wu EB, Brilakis ES, Mashayekhi K, et al. Global chronic total occlusion crossing algorithm. JACC. 2021;78(8):840-853.
Ybarra LF, Rinfret S, Brilakis ES, et al. Definitions and clinical trial design principles for coronary artery chronic total occlusion therapies: CTO-ARC consensus recommendations. Circulation. 2021;143(5):479-500.
Patel VG, Michael TT, Mogabgab O, et al. Clinical, angiographic, and procedural predictors of periprocedural complications during chronic total occlusion percutaneous coronary intervention. J Invasive Cardiol. 2014;26(3):100-105.
Galassi AR, Sianos G, Werner GS, et al. Retrograde recanalization of chronic total occlusions in Europe. JACC. 2015;65(22):2388-2400.
Wu CJ, Fang HY, Cheng CI, et al. The safety and feasibility of bilateral radial approach in chronic total occlusion percutaneous coronary intervention. Int Heart J. 2011;52(3):131-138.
Allana SS, Brilakis ES. The importance of the “safety coronary guidewire” in the donor vessel during chronic total occlusion percutaneous coronary intervention. cardiovascular revascularization. Medicine. 2023;23S:1553-8389.
Azzalini L, Brilakis ES, Carlino M. [Acute vessel closure due to spontaneous or iatrogenic coronary dissection: salvage techniques]. G Ital Cardiol (Rome). 2020;21(6 suppl 1):35.
Avula V, Karacsonyi J, Hammadah M, Brilakis ES. Venoarterial extracorporeal membrane oxygenation for life-threatening complications of percutaneous coronary and structural heart interventions. Cardiovasc Revasc Med. 2022;40S:308-311.
Karacsonyi J, Deffenbacher K, Benzuly KH, et al. Use of mechanical circulatory support in chronic total occlusion percutaneous coronary intervention. Am J Cardiol. 2023;189:76-85.
Shaukat A, Hryniewicz-Czeneszew K, Sun B, et al. Outcomes of extracorporeal membrane oxygenation support for complex High-Risk elective percutaneous coronary interventions: a single-center experience and review of the literature. J Invasive Cardiol. 2018;30(12):456-460.
Xenogiannis I, Hryniewicz K, Burke MN, Brilakis ES. Salvage of simultaneous acute coronary closure and retroperitoneal bleeding using veno-arterial extracorporeal membrane oxygenation and chronic total occlusion percutaneous coronary intervention techniques in a patient with ST-segment elevation myocardial infarction. Cardiovasc Revasc Med. 2019;20(11S):42-45.
Duong T, Christopoulos G, Luna M, et al. Frequency, indications, and outcomes of guide catheter extension use in percutaneous coronary intervention. J Invasive Cardiol. 2015;27(10):211-215.

Auteurs

Spyridon Kostantinis (S)

Department of Cardiology, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Athanasios Rempakos (A)

Department of Cardiology, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Bahadir Simsek (B)

Department of Cardiology, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Judit Karacsonyi (J)

Department of Cardiology, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Salman S Allana (SS)

Department of Cardiology, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Khaldoon Alaswad (K)

Department of Cardiology, Henry Ford Cardiovascular Division, Detroit, Michigan, USA.

Mir B Basir (MB)

Department of Cardiology, Henry Ford Cardiovascular Division, Detroit, Michigan, USA.

Oleg Krestyaninov (O)

Department of Cardiology, Meshalkin Novosibirsk Research Institute, Novosibirsk, Russia.

Dmitrii Khelimskii (D)

Department of Cardiology, Meshalkin Novosibirsk Research Institute, Novosibirsk, Russia.

Sevket Gorgulu (S)

Department of Cardiology, Biruni University Medical School, Istanbul, Turkey.

Rhian E Davies (RE)

Department of Cardiology, Wellspan York Hospital, York, Pennsylvania, USA.

Stewart M Benton (SM)

Department of Cardiology, Wellspan York Hospital, York, Pennsylvania, USA.

Jaikirshan J Khatri (JJ)

Department of Cardiology, Cleveland Clinic, Cleveland, Ohio, USA.

Paul Poommipanit (P)

Department of Cardiology, University Hospitals, Case Western Reserve University, Cleveland, Ohio, USA.

James W Choi (JW)

Department of Cardiology, Texas Health Presbyterian Hospital, Dallas, Texas, USA.

Wissam A Jaber (WA)

Department of Cardiology, Emory University Hospital Midtown, Atlanta, Georgia, USA.

Stephane Rinfret (S)

Department of Cardiology, Emory University Hospital Midtown, Atlanta, Georgia, USA.

William Nicholson (W)

Department of Cardiology, Emory University Hospital Midtown, Atlanta, Georgia, USA.

Karim M Al-Azizi (KM)

Department of Cardiology, The Heart Hospital - Plano, Plano, Texas, USA.

Srinivasa Potluri (S)

Department of Cardiology, The Heart Hospital - Plano, Plano, Texas, USA.

Nazif Aygul (N)

Department of Cardiology, Selcuk University Medical Faculty, Konya, Turkey.

Bulent B Altunkeser (BB)

Department of Cardiology, Selcuk University Medical Faculty, Konya, Turkey.

Michael Koutouzis (M)

Department of Cardiology, Red Cross Hospital of Athens, Athens, Greece.

Ioannis Tsiafoutis (I)

Department of Cardiology, Red Cross Hospital of Athens, Athens, Greece.

Anastasios Milkas (A)

Department of Cardiology, Athens Naval and Veterans Hospital, Athens, Greece.

Ahmed M ElGuindy (AM)

Department of Cardiology, Aswan Heart Center, Magdi Yacoub Foundation, Cairo, Egypt.

Nidal Abi Rafeh (N)

Department of Cardiology, North Oaks Health System, Hammond, Los Angeles, USA.

Omer Goktekin (O)

Department of Cardiology, Memorial Bahcelievler Hospital, Istanbul, Turkey.

Olga C Mastrodemos (OC)

Department of Cardiology, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Bavana V Rangan (BV)

Department of Cardiology, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Yader Sandoval (Y)

Department of Cardiology, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

M Nicholas Burke (MN)

Department of Cardiology, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Emmanouil S Brilakis (ES)

Department of Cardiology, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Classifications MeSH